# Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users

> **NCT04205929** · PHASE4 · COMPLETED · sponsor: **Oregon Health and Science University** · enrollment: 58 (actual)

## Conditions studied

- Bleeding
- Implants
- Breakthrough Bleeding

## Interventions

- **DRUG:** Placebo
- **DRUG:** Curcumin

## Key facts

- **NCT ID:** NCT04205929
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-15
- **Primary completion:** 2022-11-05
- **Final completion:** 2023-08-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04205929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04205929, "Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04205929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*